Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- Coherus Oncology, Inc.Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026Coherus Oncology, Inc. (Nasdaq: CHRS) today announced that the Company will release interim clinical data related to its tagmokitug development program evaluating the cytolytic CCR8 antibody with toripalimab in multiple solid tumors on Wednesday, October 28, 2026. Coherus management will host a webcast from 4:30 p.m. to 6:00 p.m. Eastern Daylight Time to discuss the data and provide additional context. The company has invited key opinion leaders to join the webcast and provide their clinical perspective.
- Janice Dolnick Highlights Ethical Considerations for AI Use in Legal Nurse ConsultingLegal Forensic Nursing Expert Calls for Human Clinical Judgment, Responsible Billing and Careful Review as AI Enters Medical-Legal Casework
- Dr. Wael Sakr ScholarshipDr. Wael Sakr Scholarship for Medical Students Opens Applications for Aspiring Physicians NationwideOne-time scholarship invites pre-med undergraduates to share their path to medicine through a personal essay
- Owens & MinorOwens & Minor Launches New Innovation for the Operating RoomARMOR-FLEX* Sterilization Wrap, now available in the Halyard® product portfolio, was developed in-house to help prevent sterility breaches that can potentially compromise patient safety and lead to delays in the operating room Patent-pending ASSURE-DRY* technology and proprietary...
- Nova Leap Health Corp. to Highlight Record Performance at Planet MicroCap Showcase TorontoNOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
- The VIVA FoundationLate-Breaking Clinical Trial Results Announced at VIVA 2026The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced results from Late-Breaking Clinical Trial sessions at VIVA 2026, held at Bellagio...
- Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib for Use as a First-line Treatment Option for Unresectable or Metastatic Hepatocellular CarcinomaElevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients with cancer, today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational drug rivoceranib, an oral VEGF-TKI, in combination with camrelizumab, an anti-PD-1 antibody, as a first-line systemic treatment option for unresectable or metastatic hepatocellular carcinoma (uHCC).
- Global Animal Model Market - Size, Share, Trends, and Forecast, 2021-2031F | 8.53% CAGR Opportunity Fueled by Humanized Models and CRO OutsourcingHumanized models improve clinical translatability, while CRO outsourcing converts fixed costs into variable spend and provides specialized expertise
- Cochlear North AmericaCochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026Newsweek's World's Most Trustworthy Companies 2026 Ranks Cochlear as Top Healthcare & Life Sciences Company — Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been ranked No. 1 in the Health Care &...
- WeInfuseWeInfuse and Clarion Partner to Bring AI Agents to the Infusion and Pharmacy Front OfficeClarion's AI agents connect directly to WeInfuse to resolve routine patient calls using live order, authorization, and appointment data. — WeInfuse, the premier software platform for infusion providers and pharmacies, announced a strategic partnership...
- NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug DevelopmentNeOnc (NASDAQ:NTHI) is strengthening its boardroom, as its clinical-development progress seeks to advance treatments for some of the most difficult cancers
- TruSolace Healing Center Now Treats Skin, Weight, and Sleep Concerns Together in One Visit Instead of Separate AppointmentsThe Sandy medical spa's coordinated intake process identifies the shared root cause when aesthetic, hormonal, and metabolic changes occur simultaneously. Sandy, — TruSolace Healing Center, a medical spa in Sandy, Utah, now structures every first visit aroun…